honokiol has been researched along with Angiosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbiser, JL; Bai, X; Battle, T; Campbell, PM; Cerimele, F; Der, CJ; Dubiel, W; Frank, DA; Govindarajan, B; Murad, E; Soff, G; Ushio-Fukai, M; Waqas, M; Ye, K | 1 |
| Arbiser, JL; Bhandarkar, S; Cance, WG; Funa, NS; Kurenova, EV; Reddy, K; Welsh, M; Yang, L | 1 |
2 other study(ies) available for honokiol and Angiosarcoma
| Article | Year |
|---|---|
Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biphenyl Compounds; Cell Division; Cell Line; Cell Line, Transformed; Endothelium, Vascular; Hemangiosarcoma; Humans; Lignans; Magnolia; MAP Kinase Signaling System; Mice; Mice, Nude; Phytotherapy; Plant Extracts; Transplantation, Heterologous | 2003 |
Shb gene knockdown increases the susceptibility of SVR endothelial tumor cells to apoptotic stimuli in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cisplatin; Endothelial Cells; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Hemangiosarcoma; In Vitro Techniques; Lignans; Mice; Mice, Nude; Mutagenesis; Neoplasm Transplantation; Neovascularization, Pathologic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Staurosporine | 2008 |